NO333366B1 - Aktivert skum - Google Patents

Aktivert skum Download PDF

Info

Publication number
NO333366B1
NO333366B1 NO20062808A NO20062808A NO333366B1 NO 333366 B1 NO333366 B1 NO 333366B1 NO 20062808 A NO20062808 A NO 20062808A NO 20062808 A NO20062808 A NO 20062808A NO 333366 B1 NO333366 B1 NO 333366B1
Authority
NO
Norway
Prior art keywords
foam
activated
activated foam
cells
prostate cancer
Prior art date
Application number
NO20062808A
Other languages
English (en)
Norwegian (no)
Other versions
NO20062808L (no
Inventor
Tomizo Yamamoto
Original Assignee
Tomizo Yamamoto
Shima Hiroki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomizo Yamamoto, Shima Hiroki filed Critical Tomizo Yamamoto
Publication of NO20062808L publication Critical patent/NO20062808L/no
Publication of NO333366B1 publication Critical patent/NO333366B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20062808A 2005-04-29 2006-06-15 Aktivert skum NO333366B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005160403 2005-04-29
PCT/JP2005/008906 WO2006117881A1 (ja) 2005-04-29 2005-05-16 活性発泡体

Publications (2)

Publication Number Publication Date
NO20062808L NO20062808L (no) 2007-05-08
NO333366B1 true NO333366B1 (no) 2013-05-13

Family

ID=37307688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062808A NO333366B1 (no) 2005-04-29 2006-06-15 Aktivert skum

Country Status (17)

Country Link
US (2) US20070254034A1 (ja)
EP (1) EP1902718B1 (ja)
JP (2) JP5932194B2 (ja)
KR (1) KR100871643B1 (ja)
CN (1) CN100589795C (ja)
AU (1) AU2005330574B8 (ja)
BR (1) BRPI0510510B8 (ja)
CA (1) CA2567807C (ja)
HK (1) HK1111891A1 (ja)
MX (1) MXPA06013339A (ja)
NO (1) NO333366B1 (ja)
NZ (1) NZ548087A (ja)
RU (1) RU2343901C2 (ja)
TW (1) TW200643072A (ja)
UA (1) UA84762C2 (ja)
WO (1) WO2006117881A1 (ja)
ZA (1) ZA200605814B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9344246B2 (en) 2010-10-08 2016-05-17 Qualcomm Incorporated Reference signal configuration and relay downlink control channel
US9130725B2 (en) 2010-11-02 2015-09-08 Qualcomm Incorporated Interaction of PDSCH resource mapping, CSI-RS, and muting

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234039A (ja) * 1968-02-22 1971-06-03
JPS56141333A (en) * 1980-04-08 1981-11-05 Inoue Mtp Co Ltd Synthetic resin foam having healthful action
US4890872A (en) * 1986-10-08 1990-01-02 Webcraft Technologies, Inc. Flat paper sheet item for distributing a thin layer of material
JPH01182030A (ja) 1988-01-14 1989-07-19 Yuji Oku 合成ゴム発泡体
US6007817A (en) * 1988-10-11 1999-12-28 University Of Southern California Vasopermeability enhancing immunoconjugates
JPH0347126A (ja) 1989-02-03 1991-02-28 Taisho Pharmaceut Co Ltd 制癌剤
US5051288A (en) 1989-03-16 1991-09-24 International Business Machines Corporation Thin film magnetic recording disk comprising alternating layers of a CoNi or CoPt alloy and a non-magnetic spacer layer
JPH0341702A (ja) 1989-07-10 1991-02-22 Mitsubishi Electric Corp 超電導コイル
JPH03107831A (ja) 1989-09-21 1991-05-08 Sony Corp 撮像装置
JP2873730B2 (ja) 1990-08-01 1999-03-24 大日本除虫菊株式会社 表在癌および深部癌治療具
JPH04187634A (ja) 1990-11-21 1992-07-06 Kyowa Hakko Kogyo Co Ltd リポソーム製剤
JPH065949A (ja) 1992-06-19 1994-01-14 Fujikura Ltd 圧電体フィルムの製法
JPH06321789A (ja) * 1993-05-11 1994-11-22 Ikuo Ogata ゲルマニウム軟膏剤
JPH0796045A (ja) 1993-06-10 1995-04-11 Sotaro Osato 癌の遠赤外線温熱治療具
JP3208252B2 (ja) 1994-06-22 2001-09-10 大井電気株式会社 文字を数字に変換し表示する機能を有する選択呼出受信機
KR960039576A (ko) 1995-04-28 1996-11-25 이나바 세이우에몬 서보 모터용 인버터의 회생 저항 보호 방법 및 보호 장치
TW407137B (en) * 1996-10-21 2000-10-01 Food Industry Res & Dev Inst Process for separating organogermanium compounds and inorganogermanium compounds from a germanium-containing pharmaceutical plant or its processed products
JPH10245703A (ja) 1997-02-28 1998-09-14 Suzuki:Kk 遠赤外線放射衣類
JPH11116488A (ja) * 1997-10-08 1999-04-27 Toagosei Co Ltd 制癌剤
US6616925B1 (en) 1998-04-02 2003-09-09 I.D.M. Immuno-Designed Molecules Combined preparation for the treatment of neoplasic diseases or of infectious diseases
JP2002510656A (ja) 1998-04-03 2002-04-09 デュポン ファーマシューティカルズ カンパニー 放射性薬物デリバリーシステム用無機物質
JP4405602B2 (ja) * 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
JPH11310537A (ja) 1998-04-27 1999-11-09 Toagosei Co Ltd 温熱療法及び薬剤
JP2000034228A (ja) 1998-07-17 2000-02-02 Mitsubishi Chemicals Corp 頚椎捻挫治療剤
RU2147222C1 (ru) 1999-02-02 2000-04-10 Матковская Татьяна Александровна Средство для ухода за полостью рта
MXPA02005641A (es) 1999-12-10 2002-09-02 Exxon Chemical Patents Inc Articulos formados a partir de copolimeros de propileno y dieno.
EP1621312A3 (en) * 2000-06-22 2009-09-30 Mitsui Chemicals, Inc. Thermoplastic resin foam product
JP2002219182A (ja) 2001-01-24 2002-08-06 Tokyo Kaken Kk 遠赤外線腫瘍治療具
WO2002062403A1 (en) * 2001-02-08 2002-08-15 Coloplast A/S A medical dressing comprising an antimicrobial silver compound
US6455610B1 (en) * 2001-03-23 2002-09-24 Milliken & Company Antimicrobial pre-vulcanized rubber compositions
JP2003002826A (ja) * 2001-06-20 2003-01-08 Nippon Hanekku:Kk マイナスイオン発生外用貼付剤
JP2003082141A (ja) 2001-09-13 2003-03-19 Mitsubishi Chemicals Corp 脂肪族ポリエステル系樹脂押出発泡体
JP2003231638A (ja) * 2002-02-04 2003-08-19 Nihon Kankyo Science Co Ltd 鼻用血行促進補助テープ
JP2003238398A (ja) * 2002-02-08 2003-08-27 Tenshindo Sanwa:Kk 人体内不純物排出促進方法
JP2003268143A (ja) 2002-03-15 2003-09-25 Mitsubishi Chemicals Corp 発泡体製造用脂肪族ポリエステル系樹脂及び発泡体
EP1501489A4 (en) * 2002-04-15 2007-11-21 Sloan Kettering Inst Cancer COMBINATION THERAPY FOR THE TREATMENT OF CANCER
JP2003160774A (ja) * 2002-10-23 2003-06-06 Nisshin Giken Kk 機能性貼布材
JP2005002374A (ja) * 2003-06-10 2005-01-06 Toyo Shoji Kk 健康増進具とその製造方法
DE602004027244D1 (de) * 2003-06-27 2010-07-01 Astellas Pharma Inc Therapeutisches mittel für ein weichteilsarkom
US7056773B2 (en) * 2004-04-28 2006-06-06 International Business Machines Corporation Backgated FinFET having different oxide thicknesses
JP3107831U (ja) * 2004-09-21 2005-02-17 株式会社イヴ ネックウォーマ

Also Published As

Publication number Publication date
HK1111891A1 (en) 2008-08-22
AU2005330574A1 (en) 2006-12-07
ZA200605814B (en) 2007-04-25
RU2006140873A (ru) 2008-05-27
EP1902718A4 (en) 2008-08-27
KR100871643B1 (ko) 2008-12-02
CA2567807C (en) 2011-03-08
RU2343901C2 (ru) 2009-01-20
US20100316718A1 (en) 2010-12-16
WO2006117881A1 (ja) 2006-11-09
JPWO2006117881A1 (ja) 2008-12-18
NZ548087A (en) 2010-10-29
CN1953758A (zh) 2007-04-25
JP5932194B2 (ja) 2016-06-08
UA84762C2 (en) 2008-11-25
JP5977009B2 (ja) 2016-08-24
JP2012021018A (ja) 2012-02-02
EP1902718B1 (en) 2012-06-20
AU2005330574B2 (en) 2011-12-08
CN100589795C (zh) 2010-02-17
AU2005330574B8 (en) 2012-01-19
CA2567807A1 (en) 2006-11-09
MXPA06013339A (es) 2007-03-26
BRPI0510510A (pt) 2007-10-30
US20070254034A1 (en) 2007-11-01
US9125819B2 (en) 2015-09-08
TWI331616B (ja) 2010-10-11
TW200643072A (en) 2006-12-16
EP1902718A1 (en) 2008-03-26
NO20062808L (no) 2007-05-08
AU2005330574A8 (en) 2008-12-11
BRPI0510510B8 (pt) 2021-07-27
BRPI0510510B1 (pt) 2019-04-16
KR20070088257A (ko) 2007-08-29

Similar Documents

Publication Publication Date Title
Galper et al. Diagnosis and management of mycosis fungoides
Xu et al. Physical activity and breast cancer prevention: possible role of immune mediators
Malvicini et al. Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12
Reijmen et al. Fractionated radiation severely reduces the number of CD8+ T cells and mature antigen presenting cells within lung tumors
NO333366B1 (no) Aktivert skum
Yin et al. Ferroptosis and cancer immunotherapy
Morgan et al. Polyamine-polyamine oxidase interaction: part of maternal protective mechanism against fetal rejection.
Dummer et al. Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
Gamsiz et al. Evaluation of mycosis fungoides management by total skin electron beam therapy with “translational technique”
Hane et al. Extraordinarily large, giant spider angioma in an alcoholic cirrhotic patient.
Zgolli et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by imatinib
Meduri et al. Corticosteroids in ARDS: a counterpoint
Catanoso et al. Improved T-and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel)
Vaughan-Shaw et al. Rectal Cancer genes down-regulated by Vitamin D (3,200 IU only helped some)–RCT Aug 2021
Samhouri et al. Comparison of Two Different Doses of Anti-Thymocyte Globulin in Preventing GVHD Based on Recipient Absolute Lymphocyte Count
Yaoqin et al. The enhancement of Tween-80 on the antitumor effect of the hyperthermia 41 C in tumor-bearing mice
Kawaguchi et al. Correlation between Docetaxel-Induced Skin Toxicity and the use of Steroids and H2 Blockers: A Multi-Institution Survey
Morishita et al. The Efficacy of R-Thrombomodulin in Comparison with Dalteparin NA in 26 Patients with Hematological Malignancy Complicated by DIC
Tamiya et al. Prospective Study of Switch from Oral Medicine of Tramadolto Fentanyl Sticking Medicine in Thoracic Malignancy with the Pain
Xiao et al. Contribution of CCDC134, a Potential Cytokine, to CD8~+ T Cell Effector Functions in Cancer Immunotherapy
Nomura et al. Irsogladine Maleate Reduces the Incidence of Oral Mucositis in Patients Receiving Fluorouracil-Based Chemotherapy: A Pilot Study
de Oliveira et al. Cell Death Induced By Tamoxifen In Human Blood Lymphocytes Cultivated In Vitro [morte Celular Induzida Pelo Tamoxifeno Em Linfócitos Humanos Cultivados In Vitro]
Zilembo et al. Hormonal-therapy in patients with stage-iv breast-cancer at diagnosis
Wolf et al. 76th Annual Meeting of the Swiss Society for Dermatology and Venereology
Tuma High-Risk Melanoma: Phase III Data on Antisense BCL-2 (Oblimersen), Phase II Data on GM-CSF Adjuvant Therapy